{"id":"W2051776695","doi":"10.1038/sj.npp.1300690","title":"A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment","year":2005,"lang":"en","type":"article","venue":"Neuropsychopharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"School of Medicine, New York University; York University; Towson University; Dartmouth College; University of Illinois at Urbana-Champaign; University of Rochester","keywords":"Rofecoxib; Placebo; Medicine; Clinical Dementia Rating; Internal medicine; Hazard ratio; Celecoxib; Alzheimer's disease; Randomized controlled trial; Disease; Confidence interval; Cyclooxygenase; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01794150667371901,"score_gpt":0.3222065832068268,"score_spread":0.3042650765331078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}